Leading innovation for patients

Advanced Accelerator Applications develops, produces and commercializes drugs for targeted radioligand therapy and precision radioligand imaging.

Our expertise is built on a more than 15-year legacy of manufacturing and commercializing a portfolio of PET and SPECT nuclear medicine imaging products for a number of indications in oncology, neurology, cardiology and infectious & inflammatory diseases.

LOCAMETZ®

Kit for the preparation of gallium Ga 68 gozetotide injection

SmPC

PLUVICTO®

Our brand name for lutetium Lu 177 vipivotide tetraxetan

SmPC

LUTATHERA®

Our brand names for lutetium Lu 177 dotatate / lutetium (177Lu) oxodotreotide

SmPC

NETSPOT®

Kit for the preparation of gallium Ga 68 dotatate injection

PI

SOMAKIT TOC®

Kit for the preparation of gallium (Ga 68) edotreotide solution

SmPC

LysaKare

LysaKare® 25g/25g solution for reduction of renal (kidney) radiation exposure during peptide-receptor radionuclide therapy with Lutathera®

SmPC

GLUSCAN / BARNASCAN

Advanced Accelerator Applications brand names for FDG (most widely used PET tracer)

Oncology
Cardiology
Neurology
Infectious and inflammatory diseases

SmPC

DOPAVIEW / PADOVIEW

Advanced Accelerator Applications brand names for 6-fluoro-[18F]-L-DOPA, a DOPA analog

Neurology
Oncology

SmPC

FLUOROCHOL / AAACHOLINE / CHOLSCAN

Advanced Accelerator Applications brand names for [18F]-choline (FCH)

Oncology